Clinical Trial Update: CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial (NCT00129870) comparing oxaliplatin versus conventional methods with calcium/magnesium in first-line metastatic colorectal cancer has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Calcium/Magnesium (calcium/magnesium)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer | Phase 4 | Status: TERMINATED